IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $911,929 | -75.6% | 200,424 | -62.2% | 0.00% | -77.8% |
| Q2 2023 | $3,732,200 | -45.9% | 530,142 | -53.0% | 0.02% | -47.1% |
| Q1 2023 | $6,897,658 | -36.9% | 1,128,913 | -34.0% | 0.03% | -44.3% |
| Q4 2022 | $10,932,280 | -20.9% | 1,710,842 | +18.6% | 0.06% | -18.7% |
| Q3 2022 | $13,824,000 | +24.6% | 1,443,048 | +43.6% | 0.08% | +31.6% |
| Q2 2022 | $11,096,000 | -10.6% | 1,005,107 | +34.9% | 0.06% | -18.6% |
| Q1 2022 | $12,408,000 | +7.7% | 745,212 | +23.4% | 0.07% | +11.1% |
| Q4 2021 | $11,524,000 | -26.8% | 603,676 | -5.4% | 0.06% | -37.6% |
| Q3 2021 | $15,744,000 | -12.8% | 638,434 | -8.0% | 0.10% | -19.2% |
| Q2 2021 | $18,048,000 | +577.7% | 693,617 | +724.6% | 0.12% | +557.9% |
| Q1 2021 | $2,663,000 | +58.0% | 84,111 | +131.6% | 0.02% | +35.7% |
| Q4 2020 | $1,685,000 | – | 36,311 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |